In this study, we determined the distribution of GSTM1 and GSTT1 polymorphisms in patients with chronic HCV grouped according to stage of liver disease (chronic hepatitis, cirrhosis, and HCC), with a view to investigating their potential involvement in risk of disease progression in Brazilian patients with chronic hepatitis C infection. This evidence concerns the gene GSTM1 and hepatocellular carcinoma.